New book in Dutch

Eet vet word slank

Eet vet word slank gepubliceerd januari 2013

In dit boek lees je o.a.: * heel veel informatie ter bevordering van je gezondheid; * hoe je door de juiste vetten te eten en te drinken kan afvallen; * hoe de overheid en de voedingsindustrie ons, uit financieel belang, verkeerd voorlichten; * dat je van bewerkte vetten ziek kan worden.

Trick and Treat:
How 'healthy eating' is making us ill
Trick and Treat cover

"A great book that shatters so many of the nutritional fantasies and fads of the last twenty years. Read it and prolong your life."
Clarissa Dickson Wright

Natural Health & Weight Loss cover

"NH&WL may be the best non-technical book on diet ever written"
Joel Kauffman, PhD, Professor Emeritus, University of the Sciences, Philadelphia, PA

Soy Online Service

Hot News!

Archived Hot News!


FDA to Reevaluate Scientific Basis for Previously Authorized Soy Health Claims

Federal Register -- December 21, 2007

The Food and Drug Administration (FDA) is announcing an opportunity for public comment on its intent to reevaluate the scientific evidence for two previously authorized health claims (dietary lipids (fat) and cancer; soy protein and risk of coronary heart disease) and two qualified health claims that were the subject of letters of enforcement discretion (antioxidant vitamins and risk of certain cancers; selenium and certain cancers). The agency is undertaking a reevaluation of the scientific basis for these authorized health claims and qualified health claims because of new scientific evidence that has emerged for these substance-disease relationships. The new scientific evidence may have the effect of weakening the substance-disease relationship for these authorized health claims and either strengthening or weakening the scientific support for the substance-disease relationship for these qualified health claims.

Read more here.


Report of the NZ House of Representatives Health Committee on Petition 2005/123
of Valerie Ann James and 214 others, submitted with the support of SoyOnlineService. 14-Dec-2007

The committee heard evidence on 17 October 2007 from Valerie Ann James, the New Zealand Food Safety Authority and the Ministry of Health.

"Conclusion: We support the petitioner's request for more accurate labels on soy-based infant formula, which highlight the potential long-term risks of feeding soy-based infant formula to infants. We accept that there is evidence that soy-based formulas have a high phytoestrogen content that may pose a risk to the long-term reproductive health of infants. We acknowledge that the current labels do advise consumers to consult a doctor or health care worker for advice. However, we believe it would be prudent to supplement this advice with more specific wording which points out that the high phytoestrogen content of soy-based infant formula may pose a risk to the long term reproductive health of infants."...

. Read the full report here


Caution urged over 'gulps of goodness'
'Functional Foods' - also known as 'neutraceuticals' or 'designer foods' - must be monitored to assess long-term safety and effectiveness, say a group of scientists writing in today's British Medical Journal. Nynke de Jong, project director at the Duth Institute and colleagues, focused on the potential risks of cholesterol lowering margarines and yoghurts. These products, he wrote, could trigger reactions in people taking statins - drugs that do the same job but act more powerfully - which might actually increase their risk of heart disease, the Dutch experts say. The margarines contain plant sterols which lower cholesterol but when eaten by people taking statins, the level of plant sterols in their blood is raised. There are concerns that this could increase the thickening of the arteries - and the risk of a heart attack - and Canada has banned the sale of these product. Download the British Medical Journal article here. Also see a related article in the NZ Hearld, 21st May 2007.


Death by Veganism
New York Times; May 21 2007, by NINA PLANCK.   WHEN Crown Shakur died of starvation, he was 6 weeks old and weighed 3.5 pounds. His vegan parents, who fed him mainly soy milk and apple juice, were convicted in Atlanta recently of murder, involuntary manslaughter and cruelty.This particular calamity — at least the third such conviction of vegan parents in four years — may be largely due to ignorance. But it should prompt frank discussion about nutrition. Read the full article here.


Prime TV Broadcast - Soy Cancer Warning ... Click here to view a short news article that aired on Australia's Prime TV on the health warning to cancer patients and the potential harm of soy products Download the cip here (6MB)


CANCER patients are being warned to avoid foods rich in soy because they can accelerate the growth of tumours.
The Cancer Council NSW will issue guidelines today, warning about the dangers of high-soy diets and soy supplements for cancer patients and those people in remission from cancer. "The Cancer Council does not support the use of health claims on food labels that suggest soy foods or phyto-oestrogens protect against the development of cancer.'' Read the article here!


Review casts doubt on soy health benefits - Veggie burgers and tofu might not be so great at warding off heart disease after all. An American Heart Association committee reviewed a decade of studies on soy's benefits and came up with results that are now casting doubt on the health claim that soy-based foods and supplements significantly lower cholesterol. Read More about this here.


Public kept in dark over soy milk scare
Source: Sunday Star Times 14 May 2006, By EMILY WATT

A soy milk with over 1000 times more iodine than other brands left five people sick, and many more may have been unaware they were ill. Authorities did not alert the public to the health risk once it was discovered, despite the likelihood others were similarly poisoned. Read more on this here


Federal Panel to Explore Possible Health Risks of Genistein, Soy Formula; Comment Invited


The Center for the Evaluation of Risks to Human Reproduction (CERHR) announces availability of the two draft expert panel reports on genistein and soy formula on January 16, 2006, from the CERHR Web site or in printed text from CERHR. CERHR invites public comments on sections 1-4 of both draft expert panel reports.

The expert panel meeting for genistein and soy formula will be held at the Radisson Hotel Old Town, 901 N. Fairfax Street, Alexandria, Virginia 22314-1501 (telephone: 703-683-6000, facsimile: 703-683-7597).

Comment Invited:
Comments on the draft expert panel reports and any other correspondence should be sent to Dr. Michael D. Shelby, CERHR Director, NIEHS, P.O. Box 12233, MD EC-32, Research Triangle Park, NC 27709 (mail), (919) 316-4511 (fax), or (e-mail). Courier address: CERHR, NIEHS, 79 T.W. Alexander Drive, Building 4401, Room 103, Research Triangle Park, NC 27709.

More information on these reports and how to comment can be found here.

from - A substance found in soy-based infant formula and over-the-counter dietary supplements affects the development of ovaries and eggs in female infant mice, according to a study conducted by researchers at the National Institutes of Health (NIH) and Syracuse University. Read the article here.


Review casts doubt on soy health benefits

Veggie burgers and tofu might not be so great at warding off heart disease after all. An American Heart Association committee reviewed a decade of studies on soy's benefits and came up with results that are now casting doubt on the health claim that soy-based foods and supplements significantly lower cholesterol. Read More about this here.


Component in Soy Products Causes Reproductive Problems in Laboratory Mice

From NIH News - National Institutes of Health

January 10, 2006

Genistein, a major component of soy, was found to disrupt the development of the ovaries in newborn female mice that were given the product. This study adds to a growing body of literature demonstrating the potentially adverse consequences of genistein on the reproductive system.

“Although we are not entirely certain about how these animal studies on genistein translate to the human population, there is some reason to be cautious,” said Dr. David A. Schwartz, Director of the National Institute of Environmental Health Sciences (NIEHS). “More clinical studies are needed to determine how exposure during critical windows of development can impact human health.”

Genistein is the primary naturally occurring estrogen in plants (called phytoestrogens) and can mimic the effects of estrogen in the body. Genistein can be found in foods containing soy such as soy-based infant formulas as well as over-the-counter dietary supplements.

The results of this study conducted by researchers at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, in collaboration with an investigator at Syracuse University, are published in the January issue of Biology of Reproduction.

The NIEHS researchers previously showed that mice given genistein immediately after birth had irregular menstrual cycles, problems with ovulation, and problems with fertility as they reached adulthood. The new study looks at the direct effects of genistein on the ovaries during early development.

“We knew genistein was linked to reproductive problems later in life, but we wanted to find out when the damage occurs,” said Retha R. Newbold, MS, a developmental endocrinologist at NIEHS and an author on the study. “The study showed that genistein caused alterations to the ovaries during early development, which is partly responsible for the reproductive problems found in adult mice.”

Female mice were injected with three different doses of genistein during their first five days of life. The genistein given to the mice was comparable to what human infants might receive in a soy-based formula, which is approximately 6-9 mg/kg per day. The researchers examined the effects on days 2 through 6.

The researchers found effects at all levels. Mice treated with the high dose (Gen 50 mg/kg) were infertile and mice treated with lower doses were subfertile, meaning they had fewer pups in each litter, and fewer pregnancies. Mice receiving the highest level of genistein, 50 mg/kg per day, had a high percentage of egg cells that remain in clusters, unable to separate and therefore develop abnormally. The researchers explain that oocytes that remain in clusters are less likely to become fertilized based on previous research. The largest difference between the genistein treated and normal mice was found at six days of age where 57 percent of the egg cells in the non-treated ovaries were single or unclustered; and only 36 percent in the genistein treated group were single.

We think genistein inhibits the oocytes or egg cells from separating apart,” said Wendy Jefferson, Ph.D. of NIEHS and lead researcher on the paper. “Since there are many egg cells in the same follicle instead of just one, the resources from the surrounding cells are spread too thin and they can't get the support they need to become a mature functioning egg cell.”

“You need at least one good healthy single oocyte that is ovulated and fertilized by a sperm to get a healthy baby. Genistein seems to have a way of making this task very difficult,” said Newbold.

“I don't think we can dismiss the possibility that these phytoestrogens are having an effect on the human population,” said Dr. Jefferson. “They may not show their effects or be detected until later in life, but chances are they are having an effect.”

This illustration depicts normal egg cell development in mice as shown in the top. The bottom image shows the genistein-treated animals where the abnormal egg clustering occurs.

Note: The National Toxicology Program, Center for the Evaluation of Risks to Human Reproduction (CERHR) will hold an independent expert panel meeting on “Genistein and Soy Formula” on March 15-17, 2006, at the Radisson Hotel Old Town, Alexandria, VA. The NTP is an interagency program headquartered at NIEHS.

NIEHS, a component of the National Institutes of Health, supports research to understand the effects of the environment on human health. For more information on environmental health topics, please visit our website at

The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary Federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit

Reference: W Jefferson, E Padilla-Banks, R Newbold and M Pepling. Neonatal genistein treatment alters ovarian differentiation in the mouse: Inhibition of oocyte nest breakdown and increased oocyte survival. Biology of Reproduction, January 2006.

W Jefferson, E Padilla-Banks and R Newbold. Adverse Effects on Female Development and Reproduction in CD-1 Mice Following Neonatal Exposure to the Phytoestrogen Genistein at Environmentally Relevant Doses. Biology of Reproduction 73(4):798-806, 2005. Epub Jun 1, 2005.



Solae withdraws soy/cancer health claim petition

Nov 10 /2005

The FDA confirmed on October 4 that the Solae Company has withdrawn its petition for a soy protein and cancer health claim. Had this health claim been approved, it would have doubled the sales of soy protein in this country, bringing huge profits to the soy industry while putting American men, women and children at risk.

"This represents a major blow to the soy industry," says Kaayla T. Daniel, PhD, author of The Whole Soy Story: The Dark Side of America's Favorite Health Food. "The FDA advised Solae on at least one occasion that it had not convincingly established that soy can prevent cancer and that it had failed to counter massive evidence that soy can cause, contribute to or accelerate cancer growth."

Dr. Daniel joined the Weston Price Foundation to present much of the scientific evidence against soy that led to the FDA's questions and to Solae's withdrawal. The Weston A. Price Foundation has been a leader in alerting the public to the fact that soy protein and soy oil in the food supply have been linked to digestive distress, thyroid damage, reproductive problems, infertility, ADD/ADHD, dementia, heart disease and cancer.

Solae first petitioned the FDA for a health claim in February 2004. Food manufacturers put health claims approved by the FDA on labels and packages to increase sales because they encourage consumers to make "healthier"
purchases. The FDA had hoped to announce its final decision on October 23, 2005.

Between June 2004 and April 2005, the Weston A. Price Foundation submitted three detailed and heavily referenced documents to the FDA that refuted the claims for soy and cancer made by the Solae Company, a joint venture of Dupont and Bunge. This summer the Foundation drew the FDA's attention to a July 2005 health advisory issued by the Israeli Health Ministry that warned that soy infant formula should not be given to infants, that children should be fed soy foods no more than once per day to a maximum of three times per week and that adults should exercise caution because of increased risk of breast cancer and adverse effects on fertility.

In addition, the Foundation spearheaded a write-in campaign to the FDA earlier this year that brought in over 1,000 comments by our members requesting the FDA to not approve Solae's petition. You are all to congratulated for this fine effort.

In its petition to the FDA, Solae contended that a qualified health claim was warranted because of "substantial scientific agreement" among experts that soy protein reduces the risk of breast, prostate and colon cancers. "No such consensus exists," says Dr. Daniel. "Scientists at the FDA's own Center for Toxicological Research have warned of soy protein's carcinogenic potential and of the health dangers of excess soy-food consumption. We showed the FDA that Solae was highly selective in its choice of evidence and biased in its interpretations. We reported on the fact that they had omitted many studies proving soy to be ineffective in preventing cancer, emphasized favorable outcomes in studies with mixed results and excused the results of the few unfavorable studies that they included to give the illusion of balance. Most importantly, we drew the FDA's attention to the fact that Solae excluded many studies showing that soy protein can cause and accelerate the growth of cancer, particularly breast cancer."

In addition to the recent soy warning issued by the Israeli Health Ministry, expert scientists with the British Committee on Toxicity, Swiss Federal Health Service and other government agencies have all expressed concern about soy's potential to disrupt the digestive, immune and neuroendocrine systems of the human body and its role in rising rates of infertility, hypothyroidism and some types of cancer including thyroid and pancreatic cancers.

Soy is also highly allergenic. Most experts now place soy protein among the top eight allergens, and some rate it in the top six or even top four. The Swedish Health Ministry has warned that allergic reactions to soy are increasingly common, ranging from mild to life threatening, and that fatalities have been reported.

"People are finally starting to hear that soy is not a 'miracle food,'" says Dr. Daniel. "More and more expert scientists are issuing warnings about soy.

The FDA made a big mistake in 1999 when it kowtowed to the soy industry and allowed a soy-and-heart-disease health claim. Today's FDA is under intense scrutiny because of the Vioxx debacle and could not afford to approve an unfounded soy-prevents-cancer health claim. Solae withdrew its petition because it knew that its science was unconvincing and that the FDA had no choice but to turn them down. The bottom line is that soy does not prevent cancer."


October 3 2005

Solae withdraws soy/cancer health claim petition By Jess Halliday - FDA's record on qualified health claims approvals is causing companies to re-think their petitions. In the light of recent decisions the FDA has handed down, The Solae Company has decided to temporarily withdraw its soy/cancer prevention claim. Read about it here.


Archived Hot News!






I have removed the COMMENT facility, with regret, as I seem to be the only person who cannot leave a comment!